Hind.Bio Science, a company in the Software Products industry, reported revenue of ₹0.82 crore and net profit of ₹0.31 crore for the September 2026 quarter.
Hind.Bio Science (BSE: HINDBIO) closed at ₹6.39 on 20 Nov 2026, down 2.7% over the past year. Its market capitalisation is ₹7 crore and it trades at 41.0 times earnings.
Incorporated in 2000, Hindustan Biosciences Ltd manufactures & sells pharmaceutical products.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.